Publications by authors named "Sanjeev Pathak"

Claim this Profile
R
Recommendations for management and future investigation of psychosis in neurodegenerative disease: Findings from the International Psychogeriatric Association (IPA) working group.
Andrew A Namasivayam, Corinne E Fischer, Victor Abler, Byron Creese, Maria Paula Gastiazoro, Sanjeev Pathak

Int Psychogeriatr· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pimavanserin safety in adult and elderly patients with neuropsychiatric symptoms related to neurodegenerative disease: An open-label extension study.
Wiesław J Cubała, Ana Berrio, Katherine Chi-Burris, Gustavo Alva, Lambros Chrones, Sanjeev Pathak

J Alzheimers Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief operationalized psychosocial interventions for agitation and psychosis: Use in clinical trials and clinical care.
Clive Ballard, Kathryn Mills, Maria Soto, Jeffery Cummings, Jacobo Mintzer, Sanjeev Pathak

Int Psychogeriatr· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural history and clinical outcomes in patients with Alzheimer's disease-related psychosis by antipsychotic treatment status in the United States.
Sapna Rao, Joan Forns, Heather E Danysh, Brian Calingaert, Colleen Dempsey, Sanjeev Pathak

J Alzheimers Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges and proposed solutions to conducting Alzheimer's disease psychosis trials.
Clive Ballard, Pierre Tariot, Maria Soto-Martin, Sanjeev Pathak, I-Yuan Liu

Front Psychiatry· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety Profile of Pimavanserin Therapy in Elderly Patients with Neurodegenerative Disease-Related Neuropsychiatric Symptoms: A Phase 3B Study.
Gus Alva, Wiesław J Cubała, Ana Berrio, Bruce Coate, Victor Abler, Sanjeev Pathak

J Alzheimers Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pimavanserin for psychosis in Parkinson's disease dementia: Subgroup analysis of the HARMONY Trial.
Daniel Weintraub, Alberto J Espay, Vibhash D Sharma, Pierre N Tariot, Victor Abler, Sanjeev Pathak

Parkinsonism Relat Disord· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute haemorrhage from a large renal epithelioid angiomyolipoma: diagnostic and management considerations in a teenage patient with a rare cancer.
Samantha Conroy, Jon Griffin, Marcus Cumberbatch, Sanjeev Pathak

BMJ Case Rep· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies.
Maurizio Fava, Michael E Thase, Madhukar H Trivedi, Elliot Ehrich, William F Martin, Sanjeev Pathak

Mol Psychiatry· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Course of Psychosis in Schizophrenia With Alcohol Use Disorder: A Post Hoc Analysis of the Clinical Antipsychotic Trials of Intervention Effectiveness in Schizophrenia Phase 1 Study.
Sanjeev Pathak, Ying Jiang, Lauren DiPetrillo, Mark S Todtenkopf, Yan Liu

J Clin Psychiatry· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder.
Michael E Thase, Arielle D Stanford, Asli Memisoglu, William Martin, Amy Claxton, Sanjeev Pathak

Neuropsychopharmacology· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitigation of Olanzapine-Induced Weight Gain With Samidorphan, an Opioid Antagonist: A Randomized Double-Blind Phase 2 Study in Patients With Schizophrenia.
William F Martin, Christoph U Correll, Peter J Weiden, Ying Jiang, Sanjeev Pathak

Am J Psychiatry· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3).
John M Zajecka, Arielle D Stanford, Asli Memisoglu, William F Martin, Sanjeev Pathak

Neuropsychiatr Dis Treat· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled Trial.
Sanjeev Pathak, Bradley Vince, Debra Kelsh, Megan J Shram, Beatrice Setnik

J Clin Pharmacol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abuse Potential of Samidorphan: A Phase I, Oxycodone-, Pentazocine-, Naltrexone-, and Placebo-Controlled Study.
Sanjeev Pathak, Bradley Vince, Debra Kelsh, Beatrice Setnik, Narinder Nangia

J Clin Pharmacol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of sugarcane production technologies for enhanced cane and sugar productivity targeting to increase farmers' income: strategies and prospects.
Priyanka Singh, S N Singh, Ajay K Tiwari, Sanjeev Kumar Pathak, Anil K Singh

3 Biotech· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study.
Gerard Sanacora, Michael R Johnson, Arif Khan, Sarah D Atkinson, Robert R Riesenberg, Sanjeev Pathak

Neuropsychopharmacology· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cataractogenic potential of quetiapine versus risperidone in the long-term treatment of patients with schizophrenia or schizoaffective disorder: a randomized, open-label, ophthalmologist-masked, flexible-dose, non-inferiority trial.
Alan M Laties, Allan J Flach, Irina Baldycheva, Ihor Rak, Willie Earley, Sanjeev Pathak

J Psychopharmacol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of extended-release quetiapine fumarate in youth with bipolar depression: an 8 week, double-blind, placebo-controlled trial.
Robert L Findling, Sanjeev Pathak, Willie R Earley, Sherry Liu, Melissa P DelBello

J Child Adolesc Psychopharmacol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in patients with generalized anxiety disorder and a history of inadequate treatment response: a randomized, double-blind study.
Arifulla Khan, Sarah Atkinson, Irina Mezhebovsky, Fahua She, Todd Leathers, Sanjeev Pathak

Ann Clin Psychiatry· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in patients with generalized anxiety disorder and a history of inadequate treatment response: a randomized, double-blind study.
Arifulla Khan, Sarah Atkinson, Irina Mezhebovsky, Fahua She, Todd Leathers, Sanjeev Pathak

Ann Clin Psychiatry· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and efficacy of quetiapine in youth with schizophrenia or bipolar I disorder: a 26-week, open-label, continuation study.
Robert L Findling, Sanjeev Pathak, Willie R Earley, Sherry Liu, Melissa DelBello

J Child Adolesc Psychopharmacol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of quetiapine in children and adolescents with mania associated with bipolar I disorder: a 3-week, double-blind, placebo-controlled trial.
Sanjeev Pathak, Robert L Findling, Willie R Earley, Larisa D Acevedo, Jill Stankowski

J Clin Psychiatry· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of quetiapine in adolescents with schizophrenia investigated in a 6-week, double-blind, placebo-controlled trial.
Robert L Findling, Kathleen McKenna, Willie R Earley, Jill Stankowski, Sanjeev Pathak

J Child Adolesc Psychopharmacol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The promise of rapidly acting antidepressants: challenges and opportunities.
Mark A Smith, Sanjeev Pathak

Biol Psychiatry· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis